Theranostic targeting of CUB domain containing protein 1 (CDCP1) in pancreatic cancer

PURPOSE: The recent emergence of radioligand therapies for cancer treatment has increased enthusiasm for developing new theranostic strategies coupling both imaging and cytotoxicity in the same entity. In this study, we evaluated if CUB domain containing protein 1 (CDCP1), a single pass transmembran...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Cancer Res
Auteurs principaux: Moroz, Anna, Wang, Yung-hua, Sharib, Jeremy M., Wei, Junnian, Zhao, Ning, Huang, Yangjie, Chen, Zhuo, Martinko, Alex J., Zhuo, Jie, Lim, Shion A., Zhang, Lydia, Seo, Youngho, Carlin, Sean D., Leung, Kevin K., Collisson, Eric A., Kirkwood, Kimberly S., Wells, James A., Evans, Michael J.
Format: Artigo
Langue:Inglês
Publié: 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7367754/
https://ncbi.nlm.nih.gov/pubmed/32341034
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-20-0268
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires